LT for Unresectable Colorectal Liver Metastasis

Status Recruiting

Clinical Trial Summary

Unlike hepatocellular carcinoma, liver transplantation in patients with liver metastasis from colorectal cancer is limited in only few centers. Previously, it was not generally implemented due to lack of organs and high recurrence rates after transplantation. However, due to progressive development in treatments, good results such as increased survival rates can be expected even in liver transplant patients with liver metastasis from colorectal cancer, which is known to have poor prognosis. Therefore, the purpose of this study is to analyze the efficacy of liver transplantation as an alternative treatment for liver metastasis from colorectal cancer.

Clinical Trial Description

Surgical treatment offers a distinct survival benefit in liver metastasis of colorectal cancer (CRC LM). However, it has been estimated that only 40% of patients are candidates for curative liver resection. Liver transplantation can be considered as one of a treatment option, since all evident disease is removed during procedure. However, it is limited in only few centers due to lack of organs and high recurrence rates after transplantation. Currently, with help of development in treatments, prognosis after LT in CRC LM is improving. Recent study of LT for CRC LM from Norway demonstrated a 5-year survival of 56%. In addition, cohort study and randomized controlled trials are ongoing in Germany and Canada. Therefore, it seems to be necessary to verify the effectiveness of liver transplantation for CRC LM and to verify it as an alternative treatment if there is no other treatment. The purpose of this study is to analyze the efficacy of liver transplantation as an alternative treatment for liver metastasis from colorectal cancer. Potential participants will be evaluated for liver transplantation and must also have a willing, healthy living donor. Unresectable metastasis should be limited to the liver and stable without no other treatment such as immunotherapy, chemotherapy, surgical resection, and radiofrequency ablation. The suitability of liver transplantation will be evaluated through a multidisciplinary assessment immediately before transplantation. Those participants who undergo liver transplantation will be followed for survival, disease-free survival, and recurrence for 3 years. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04874259
Study type	Interventional
Source	Seoul National University Hospital
Contact	YoungRok Choi, MD
Phone	82-2072-0069
Email	choiyoungrok@gmail.com
Status	Recruiting
Phase	N/A
Start date	August 22, 2022
Completion date	May 2026

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT04108481` - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer	Phase 1/Phase 2
Recruiting	`NCT03562234` - The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases
Recruiting	`NCT03732235` - TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Recruiting	`NCT06126419` - Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration	N/A
Active, not recruiting	`NCT05616039` - I-FIGS Feasibility Study	N/A
Withdrawn	`NCT05175092` - Living Donor Liver Transplantation for CRC Liver Metastases	N/A
Recruiting	`NCT04798898` - Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation	N/A
Not yet recruiting	`NCT06053996` - Hepatopulmonary Radio-sterilization With Immunotherapy	N/A
Not yet recruiting	`NCT06071052` - TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens	N/A
Recruiting	`NCT04491929` - Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases
Not yet recruiting	`NCT06050200` - TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery	N/A
Enrolling by invitation	`NCT03444194` - Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility Study	N/A
Not yet recruiting	`NCT05884723` - Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis	N/A
Not yet recruiting	`NCT06185556` - COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases	Phase 2/Phase 3
Recruiting	`NCT05755672` - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Recruiting	`NCT04595266` - Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease	Phase 2
Recruiting	`NCT04701281` - Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer	Phase 1/Phase 2
Recruiting	`NCT05775146` - SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases	Phase 2
Recruiting	`NCT06200831` - Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases	N/A
Active, not recruiting	`NCT04046445` - Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer	Phase 1